A 71-year-old man with prior ST-elevation myocardial infarction treated with PCI 6 months ago is on high-intensity statin therapy. His repeat LDL cholesterol is 2.3 mmol/L. According to current CCS guidance on secondary prevention, what is the recommended LDL target or threshold at which to consider intensifying lipid-lowering therapy with a non-statin agent?